News
-
Nanabis ready for RNS trial
Tuesday | Apr 24 2018MEDLAB has confirmed that its Nanabis medicinal cannabis product is now ready for sale and delivery to Sydney's Royal North Shore Hospital, where it will be part of an "intractable pain" trial commencing next month.
-
Viagra S3 proposal for ED
Tuesday | Apr 24 2018PFIZER Australia confirmed it has made a submission to the Therapeutic Goods Administration (TGA) for inclusion of sildenafil 50mg (Viagra) in Schedule 3, as a Pharmacist Only Medicine for treatment of erectile dysfunction.
-
Compounding confab
Tuesday | Apr 24 2018COMPOUNDING solutions company Medisca has announced the first-ever World Congress of Compounding set to take place Oct 27-28, 2018 in Las Vegas, USA.
-
GSK typhoid vax cut
Tuesday | Apr 24 2018GLAXOSMITHKLINE has announced the discontinuation of its Typherix (salmonella typhi Vi polysaccharide) adult vaccine, which will be no longer available.
-
SHPA abstracts call
Tuesday | Apr 24 2018THE 44th SHPA National Conference, Medicines Management 2018 (MM2018), is calling for abstracts, with a deadline of Fri 13 Jul.
-
Quarterly rego data
Tuesday | Apr 24 2018THE Pharmacy Board of Australia has released registration data for the three months to 31 Mar.
-
ANZAC day closures
Tuesday | Apr 24 2018ALL offices of the Australian Health Practitioners Regulation Agency will be closed tomorrow due to the ANZAC Day national public holiday.
-
Guild NIP push
Tuesday | Apr 24 2018THE Pharmacy Guild of Australia said it was encouraging States and Territories to provide enhanced access to flu vaccines for vulnerable adult patient groups through pharmacies under the National Immunisation Program (NIP).
-
Up to 120 CW planned for New Zealand
Tuesday | Apr 24 2018CHEMIST Warehouse yesterday opened its second outlet across the Tasman, with an additional Auckland store part of a planned rollout of up to 120 Chemist Warehouse shops across New Zealand, according to NZ trade publication Pharmacy Today.
-
Emerade on PBS
Tuesday | Apr 24 2018THE Pharmaceutical Benefits Advisory Committee has recommended the temporary addition of adrenaline auto-injector Emerade to the PBS until 31 Aug, as a means of helping mitigate the current global supply shortage around EpiPens.
